Nanotechnology and nanotoxicology in retinopathy

International Journal of Molecular Sciences

Volumn 12, Issue 11, 2011, Pages 8288-8301

  Jo, Dong Hyun ^a,b   Lee, Tae Geol ^c   Kim, Jeong Hun ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Korea Research Institute of Standards and Science   (South Korea)

Author keywords

Blood retinal barrier; Diabetic retinopathy; Macular degeneration; Nanoparticles; Retinal degeneration; Retinal diseases; Toxicology; Uveitis

Indexed keywords

ANGIOGENESIS INHIBITOR; CHITOSAN; DNA; GELATIN; GOLD; GOLD NANOPARTICLE; INTEGRIN ANTAGONIST PEPTIDE; LIPID; MACROGOL; NANOCAPSULE; NANOCONJUGATE; NANOPARTICLE; PLASMINOGEN KRINGLE 5; POLYGLACTIN; POLYLACTIC ACID; SILICATE; SILICON DIOXIDE; SILVER; TAMOXIFEN; TITANIUM DIOXIDE; UNCLASSIFIED DRUG; VASCULOTROPIN ANTIBODY; ANGIOGENIC FACTOR;

ANTIINFLAMMATORY ACTIVITY; BLINDNESS; BLOOD RETINA BARRIER; CRYOTHERAPY; DRUG DELIVERY SYSTEM; EYE SURGERY; GENE THERAPY; HUMAN; LASER COAGULATION; NANOTECHNOLOGY; NANOTOXICOLOGY; NEUROTOXICITY; NONHUMAN; RETINA DEGENERATION; RETINA NEOVASCULARIZATION; RETINA NERVE CELL; RETINOPATHY; REVIEW; SUBRETINAL NEOVASCULARIZATION; THERAPY EFFECT; UVEITIS; CHEMISTRY; DRUG EFFECTS; METABOLISM; NERVE CELL; PATHOLOGY; PROCEDURES; RETINA; RETINAL DISEASES; TOXICOLOGY;

ANGIOGENESIS INDUCING AGENTS; BLOOD-RETINAL BARRIER; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; NEURONS; RETINA; RETINAL DISEASES; TOXICOLOGY;

EID: 82255180746     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12118288     Document Type: Review

References (62)

1. Farjo, K.M.; Ma, J.X. The potential of nanomedicine therapies to treat neovascular disease in the retina. J. Angiogenes. Res. 2010, 2, 21.
2. Diebold, Y.; Calonge, M. Applications of nanoparticles in ophthalmology. Prog. Retin. Eye Res. 2010, 29, 596-609.
3. Thrimawithana, T.R.; Young, S.; Bunt, C.R.; Green, C.; Alany, R.G. Drug delivery to the posterior segment of the eye. Drug Discov. Today 2011, 16, 270-277.
4. Jo, D.H.; Kim, J.H.; Kim, J.H. How to overcome retinal neuropathy: The fight against angiogenesis-related blindness. Arch. Pharm. Res. 2010, 33, 1557-1565.
5. Kim, J.H.; Kim, J.H.; Park, J.A.; Lee, S.W.; Kim, W.J.; Yu, Y.S.; Kim, K.W. Blood-neural barrier: Intercellular communication at glio-vascular interface. J. Biochem. Mol. Biol. 2006, 39, 339-345.
6. Cunha-Vaz, J.G. The blood-retinal barriers. Doc. Ophthalmol. 1976, 41, 287-327.
7. Kim, J.H.; Kim, J.H.; Kim, K.W.; Kim, M.H.; Yu, Y.S. Intravenously administered gold nanoparticles pass through the blood-retinal barrier depending on the particle size, and induce noretinal toxicity. Nanotechnology 2009, 20, 505101.
8. Kim, J.H.; Kim, M.H.; Jo, D.H.; Yu, Y.S.; Lee, T.G.; Kim, J.H. The inhibition of retinal neovascularization by gold nanoparticles via suppression of vegfr-2 activation. Biomaterials 2011, 32, 1865-1871.
9. Kalishwaralal, K.; Sheikpranbabu, S.; BarathManiKanth, S.; Haribalaganesh, R.; Ramkumarpandian, S.; Gurunathan, S. Gold nanoparticles inhibit vascular endothelial growth factor-induced angiogenesis and vascular permeability via src dependent pathway in retinal endothelial cells. Angiogenesis 2011, 14, 29-45.
10. Zhou, X.; Wong, L.L.; Karakoti, A.S.; Seal, S.; McGinnis, J.F. Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the vldlr knockout mouse. PLoS One 2011, 6, e16733.
11. Kim, H.; Csaky, K.G. Nanoparticle-integrin antagonist c16y peptide treatment of choroidal neovascularization in rats. J. Control. Release 2010, 142, 286-293.
12. Singh, S.R.; Grossniklaus, H.E.; Kang, S.J.; Edelhauser, H.F.; Ambati, B.K.; Kompella, U.B. Intravenous transferrin, rgd peptide and dual-targeted nanoparticles enhance anti-vegf intraceptor gene delivery to laser-induced cnv. Gene Ther. 2009, 16, 645-659.
13. Jin, J.; Zhou, K.K.; Park, K.; Hu, Y.; Xu, X.; Zheng, Z.; Tyagi, P.; Kompella, U.B.; Ma, J.X. Anti-inflammatory and antiangiogenic effects of nanoparticle-mediated delivery of a natural angiogenic inhibitor. Invest. Ophthalmol. Vis. Sci. 2011, 52, 6230-6237.
14. Park, K.; Chen, Y.; Hu, Y.; Mayo, A.S.; Kompella, U.B.; Longeras, R.; Ma, J.X. Nanoparticlemediated expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neovascularization and diabetes-induced retinal vascular leakage. Diabetes 2009, 58, 1902-1913.
15. Jo, D.H.; Kim, J.H.; Yu, Y.S.; Lee, T.G.; Kim, J.H. Antiangiogenic effect of silicate nanoparticle on retinal neovascularization induced by vascular endothelial growth factor. Nanomedicine 2011, In pess.
16. Kalishwaralal, K.; Banumathi, E.; Ram Kumar Pandian, S.; Deepak, V.; Muniyandi, J.; Eom, S.H.; Gurunathan, S. Silver nanoparticles inhibit vegf induced cell proliferation and migration in bovine retinal endothelial cells. Colloids Surf. B 2009, 73, 51-57.
17. Kalishwaralal, K.; Barathmanikanth, S.; Pandian, S.R.; Deepak, V.; Gurunathan, S. Silver nano- a trove for retinal therapies. J. Control Release 2010, 145, 76-90.
18. Sakai, T.; Kuno, N.; Takamatsu, F.; Kimura, E.; Kohno, H.; Okano, K.; Kitahara, K. Prolonged protective effect of basic fibroblast growth factor-impregnated nanoparticles in royal college of surgeons rats. Invest. Ophthalmol. Vis. Sci. 2007, 48, 3381-3387.
19. Strettoi, E.; Gargini, C.; Novelli, E.; Sala, G.; Piano, I.; Gasco, P.; Ghidoni, R. Inhibition of ceramide biosynthesis preserves photoreceptor structure and function in a mouse model of retinitis pigmentosa. Proc. Natl. Acad. Sci. USA 2010, 107, 18706-18711.
20. Chen, J.; Patil, S.; Seal, S.; McGinnis, J.F., Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat. Nanotechnol. 2006, 1, 142-150.
21. Kong, L.; Cai, X.; Zhou, X.; Wong, L.L.; Karakoti, A.S.; Seal, S.; McGinnis, J.F. Nanoceria extend photoreceptor cell lifespan in tubby mice by modulation of apoptosis/survival signaling pathways. Neurobiol. Dis. 2011, 42, 514-523.
22. Read, S.P.; Cashman, S.M.; Kumar-Singh, R. Pod nano particles expressing gdnf provide structural and functional rescue of light-induced retinal degeneration in an adult mouse. Mol. Ther. 2010, 18, 1917-1926.
23. Cai, X.; Conley, S.M.; Nash, Z.; Fliesler, S.J.; Cooper, M.J.; Naash, M.I. Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa. FASEB J. 2010, 24, 1178-1191.
24. Cai, X.; Nash, Z.; Conley, S.M.; Fliesler, S.J.; Cooper, M.J.; Naash, M.I. A partial structural and functional rescue of a retinitis pigmentosa model with compacted DNA nanoparticles. PLoS One 2009, 4, e5290.
25. de Kozak, Y.; Andrieux, K.; Villarroya, H.; Klein, C.; Thillaye-Goldenberg, B.; Naud, M.C.; Garcia, E.; Couvreur, P. Intraocular injection of tamoxifen-loaded nanoparticles: A new treatment of experimental autoimmune uveoretinitis. Eur. J. Immunol. 2004, 34, 3702-3712.
26. Sakai, T.; Kohno, H.; Ishihara, T.; Higaki, M.; Saito, S.; Matsushima, M.; Mizushima, Y.; Kitahara, K. Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate. Exp. Eye Res. 2006, 82, 657-663.
27. Saint-Geniez, M.; Maharaj, A.S.; Walshe, T.E.; Tucker, B.A.; Sekiyama, E.; Kurihara, T.; Darland, D.C.; Young, M.J.; D'Amore, P.A. Endogenous vegf is required for visual function: Evidence for a survival role on muller cells and photoreceptors. PLoS One 2008, 3, e3554.
28. Lee, S.J.; Koh, H.J. Enlargement of the foveal avascular zone in diabetic retinopathy after adjunctive intravitreal bevacizumab (avastin) with pars plana vitrectomy. J. Ocul. Pharmacol. Ther. 2009, 25, 173-174.
29. Inan, U.U.; Avci, B.; Kusbeci, T.; Kaderli, B.; Avci, R.; Temel, S.G. Preclinical safety evaluation of intravitreal injection of full-length humanized vascular endothelial growth factor antibody in rabbit eyes. Invest. Ophthalmol. Vis. Sci. 2007, 48, 1773-1781.
30. Mukherjee, P.; Bhattacharya, R.; Wang, P.; Wang, L.; Basu, S.; Nagy, J.A.; Atala, A.; Mukhopadhyay, D.; Soker, S. Antiangiogenic properties of gold nanoparticles. Clin. Cancer Res. 2005, 11, 3530-3534.
31. Panyam, J.; Dali, M.M.; Sahoo, S.K.; Ma, W.; Chakravarthi, S.S.; Amidon, G.L.; Levy, R.J.; Labhasetwar, V. Polymer degradation and in vitro release of a model protein from oly(d,llactide- co-glycolide) nano- and microparticles. J. Control. Release 2003, 92, 173-187.
32. Panyam, J.; Labhasetwar, V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 2003, 55, 329-347.
33. Rivas, M.A.; Vecino, E. Animal models and different therapies for treatment of retinitis pigmentosa. Histol. Histopathol. 2009, 24, 1295-1322.
34. Fishman, G.A. Historical evolution in the understanding of stargardt macular dystrophy. Ophthalmic. Genet. 2010, 31, 183-189.
35. Liu, M.M.; Tuo, J.; Chan, C.C. Gene therapy for ocular diseases. Br. J. Ophthalmol. 2011, 95, 604-612.
36. Lee, F.F.; Foster, C.S. Pharmacotherapy of uveitis. Expert Opin. Pharmacother. 2010, 11, 1135- 1146.
37. Okabe, J.; Kimura, H.; Kunou, N.; Okabe, K.; Kato, A.; Ogura, Y. Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate. Invest. Ophthalmol. Vis. Sci. 2003, 44, 740-744.
38. Kempen, J.H.; Altaweel, M.M.; Holbrook, J.T.; Jabs, D.A.; Louis, T.A.; Sugar, E.A.; Thorne, J.E. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: The multicenter uveitis steroid treatment trial. Ophthalmology 2011, 118, 1916-1926.
39. Tian, N. Visual experience and maturation of retinal synaptic pathways. Vision Res. 2004, 44, 3307-3316.
40. Bourges, J.L.; Gautier, S.E.; Delie, F.; Bejjani, R.A.; Jeanny, J.C.; Gurny, R.; BenEzra, D.; Behar-Cohen, F.F. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Invest. Ophthalmol. Vis. Sci. 2003, 44, 3562-3569.
41. Merodio, M.; Irache, J.M.; Valamanesh, F.; Mirshahi, M. Ocular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats. Biomaterials 2002, 23, 1587-1594.
42. Bakri, S.J.; Pulido, J.S.; Mukherjee, P.; Marler, R.J.; Mukhopadhyay, D. Absence of histologic retinal toxicity of intravitreal nanogold in a rabbit model. Retina 2008, 28, 147-149.
43. Ding, X.Q.; Quiambao, A.B.; Fitzgerald, J.B.; Cooper, M.J.; Conley, S.M.; Naash, M.I. Ocular delivery of compacted DNA-nanoparticles does not elicit toxicity in the mouse retina. PLoS One 2009, 4, e7410.
44. Hafeli, U.O.; Riffle, J.S.; Harris-Shekhawat, L.; Carmichael-Baranauskas, A.; Mark, F.; Dailey, J.P.; Bardenstein, D. Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. Mol. Pharm. 2009, 6, 1417-1428.
45. Prow, T.W.; Bhutto, I.; Kim, S.Y.; Grebe, R.; Merges, C.; McLeod, D.S.; Uno, K.; Mennon, M.; Rodriguez, L.; Leong, K.; et al. Ocular nanoparticle toxicity and transfection of the retina and retinal pigment epithelium. Nanomedicine 2008, 4, 340-349.
46. Gramowski, A.; Flossdorf, J.; Bhattacharya, K.; Jonas, L.; Lantow, M.; Rahman, Q.; Schiffmann, D.; Weiss, D.G.; Dopp, E. Nanoparticles induce changes of the electrical activity of neuronal networks on microelectrode array neurochips. Environ. Health Perspect. 2010, 118, 1363-1369.
47. Iavicoli, I.; Leso, V.; Fontana, L.; Bergamaschi, A. Toxicological effects of titanium dioxide nanoparticles: A review of in vitro mammalian studies. Eur. Rev. Med. Pharmacol. Sci. 2011, 15, 481-508.
48. Rahman, M.F.; Wang, J.; Patterson, T.A.; Saini, U.T.; Robinson, B.L.; Newport, G.D.; Murdock, R.C.; Schlager, J.J.; Hussain, S.M.; Ali, S.F. Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol. Lett. 2009, 187, 15-21.
49. Wang, J.; Rahman, M.F.; Duhart, H.M.; Newport, G.D.; Patterson, T.A.; Murdock, R.C.; Hussain, S.M.; Schlager, J.J.; Ali, S.F. Expression changes of dopaminergic system-related genes in pc12 cells induced by manganese, silver, or copper nanoparticles. Neurotoxicology 2009, 30 926-933.
50. Choi, J.; Zheng, Q.; Katz, H.E.; Guilarte, T.R. Silica-based nanoparticle uptake and cellular response by primary microglia. Environ. Health Perspect. 2010, 118, 589-595.
51. Hutter, E.; Boridy, S.; Labrecque, S.; Lalancette-Hebert, M.; Kriz, J.; Winnik, F.M.; Maysinger, D. Microglial response to gold nanoparticles. ACS Nano 2010, 4, 2595-2606.
52. Ariano, P.; Zamburlin, P.; Gilardino, A.; Mortera, R.; Onida, B.; Tomatis, M.; Ghiazza, M.; Fubini, B.; Lovisolo, D. Interaction of spherical silica nano particles with neuronal cells: Size-dependent toxicity and perturbation of calcium homeostasis. Small 2011, 7, 766-774.
53. Liu, Z.; Ren, G.; Zhang, T.; Yang, Z. Action potential changes associated with the inhibitory effects on voltage-gated sodium current of hippocampal ca1 neurons by silver nano particles. Toxicology 2009, 264, 179-184.
54. Prabhu, B.M.; Ali, S.F.; Murdock, R.C.; Hussain, S.M.; Srivatsan, M. Copper nanoparticles exert size and concentration dependent toxicity on somatosensory neurons of rat. Nanotoxicology 2010, 4, 150-160.
55. Krug, H.F.; Wick, P. Nanotoxicology: An interdisciplinary challenge. Angew. Chem. Int. Ed. Engl. 2011, 50, 1260-1278.
56. De Jong, W.H.; Hagens, W.I.; Krystek, P.; Burger, M.C.; Sips, A.J.; Geertsma, R.E. Particle sizedependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008, 29, 1912-1919.
57. Deng, X.; Luan, Q.; Chen, W.; Wang, Y.; Wu, M.; Zhang, H.; Jiao, Z. Nanosized zinc oxide particles induce neural stem cell apoptosis. Nanotechnology 2009, 20, 115101.
58. Lasagna-Reeves, C.; Gonzalez-Romero, D.; Barria, M.A.; Olmedo, I.; Clos, A.; Sadagopa Ramanujam, V.M.; Urayama, A.; Vergara, L.; Kogan, M.J.; Soto, C. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem. Biophys. Res. Commun. 2010, 393, 649-655.
59. Wang, J.; Liu, Y.; Jiao, F.; Lao, F.; Li, W.; Gu, Y.; Li, Y.; Ge, C.; Zhou, G.; Li, B.; et al. Time-dependent translocation and potential impairment on central nervous system by intranasally instilled tio(2) nanoparticles. Toxicology 2008, 254, 82-90.
60. Goodman, C.M.; McCusker, C.D.; Yilmaz, T.; Rotello, V.M. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug. Chem. 2004, 15, 897-900.
61. Lockman, P.R.; Koziara, J.M.; Mumper, R.J.; Allen, D.D. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J. Drug Target 2004, 12, 635-641.
62. Baber, O.; Jang, M.; Barber, D.; Powers, K. Amorphous silica coatings on magnetic nanoparticles enhance stability and reduce toxicity to in vitro beas-2b cells. Inhal. Toxicol. 2011, 23, 532-543.